A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
Campos SM, Berlin S, Krasner CN, Whalen C, Atkinson T, Meegan K, Pereira L, Tyburski K, Lou W, Lee H, Horowitz N, Penson RT.
Campos SM, et al. Among authors: atkinson t.
Cancer Chemother Pharmacol. 2022 Mar;89(3):423-430. doi: 10.1007/s00280-022-04399-2. Epub 2022 Feb 10.
Cancer Chemother Pharmacol. 2022.
PMID: 35142863
Clinical Trial.